MeSH
Antineoplastic Agents /economics /therapeutic use; Breast Neoplasms /drug therapy /economics; Colorectal Neoplasms /drug therapy /economics; Cost Savings; Drug Costs; Hospital Costs; Hospitalization /economics; Humans; Insurance, Health, Reimbursement; Lung Neoplasms /drug therapy /economics; Quality Assurance, Health Care